| Entry |
|
| Symbol |
PLCB1
|
| Name |
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1
|
| KO |
|
| Organism |
csyr Carlito syrichta (Philippine tarsier)
|
| Pathway |
| csyr04070 | Phosphatidylinositol signaling system |
| csyr04261 | Adrenergic signaling in cardiomyocytes |
| csyr04613 | Neutrophil extracellular trap formation |
| csyr04621 | NOD-like receptor signaling pathway |
| csyr04723 | Retrograde endocannabinoid signaling |
| csyr04750 | Inflammatory mediator regulation of TRP channels |
| csyr04925 | Aldosterone synthesis and secretion |
| csyr04928 | Parathyroid hormone synthesis, secretion and action |
| csyr04933 | AGE-RAGE signaling pathway in diabetic complications |
| csyr04935 | Growth hormone synthesis, secretion and action |
| csyr04961 | Endocrine and other factor-regulated calcium reabsorption |
| csyr04973 | Carbohydrate digestion and absorption |
| csyr05022 | Pathways of neurodegeneration - multiple diseases |
|
| Module |
| csyr_M00130 | Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 |
|
| Brite |
KEGG Orthology (KO) [BR:csyr00001]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
103257479 (PLCB1)
09130 Environmental Information Processing
09132 Signal transduction
04015 Rap1 signaling pathway
103257479 (PLCB1)
04310 Wnt signaling pathway
103257479 (PLCB1)
04371 Apelin signaling pathway
103257479 (PLCB1)
04020 Calcium signaling pathway
103257479 (PLCB1)
04070 Phosphatidylinositol signaling system
103257479 (PLCB1)
04072 Phospholipase D signaling pathway
103257479 (PLCB1)
04071 Sphingolipid signaling pathway
103257479 (PLCB1)
04022 cGMP-PKG signaling pathway
103257479 (PLCB1)
09133 Signaling molecules and interaction
04082 Neuroactive ligand signaling
103257479 (PLCB1)
04081 Hormone signaling
103257479 (PLCB1)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04540 Gap junction
103257479 (PLCB1)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
103257479 (PLCB1)
04613 Neutrophil extracellular trap formation
103257479 (PLCB1)
04621 NOD-like receptor signaling pathway
103257479 (PLCB1)
04062 Chemokine signaling pathway
103257479 (PLCB1)
09152 Endocrine system
04911 Insulin secretion
103257479 (PLCB1)
04922 Glucagon signaling pathway
103257479 (PLCB1)
04929 GnRH secretion
103257479 (PLCB1)
04912 GnRH signaling pathway
103257479 (PLCB1)
04915 Estrogen signaling pathway
103257479 (PLCB1)
04921 Oxytocin signaling pathway
103257479 (PLCB1)
04926 Relaxin signaling pathway
103257479 (PLCB1)
04935 Growth hormone synthesis, secretion and action
103257479 (PLCB1)
04918 Thyroid hormone synthesis
103257479 (PLCB1)
04919 Thyroid hormone signaling pathway
103257479 (PLCB1)
04928 Parathyroid hormone synthesis, secretion and action
103257479 (PLCB1)
04916 Melanogenesis
103257479 (PLCB1)
04924 Renin secretion
103257479 (PLCB1)
04925 Aldosterone synthesis and secretion
103257479 (PLCB1)
04927 Cortisol synthesis and secretion
103257479 (PLCB1)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
103257479 (PLCB1)
04270 Vascular smooth muscle contraction
103257479 (PLCB1)
09154 Digestive system
04970 Salivary secretion
103257479 (PLCB1)
04971 Gastric acid secretion
103257479 (PLCB1)
04972 Pancreatic secretion
103257479 (PLCB1)
04973 Carbohydrate digestion and absorption
103257479 (PLCB1)
09155 Excretory system
04961 Endocrine and other factor-regulated calcium reabsorption
103257479 (PLCB1)
09156 Nervous system
04724 Glutamatergic synapse
103257479 (PLCB1)
04725 Cholinergic synapse
103257479 (PLCB1)
04728 Dopaminergic synapse
103257479 (PLCB1)
04726 Serotonergic synapse
103257479 (PLCB1)
04720 Long-term potentiation
103257479 (PLCB1)
04730 Long-term depression
103257479 (PLCB1)
04723 Retrograde endocannabinoid signaling
103257479 (PLCB1)
09157 Sensory system
04742 Taste transduction
103257479 (PLCB1)
04750 Inflammatory mediator regulation of TRP channels
103257479 (PLCB1)
09159 Environmental adaptation
04713 Circadian entrainment
103257479 (PLCB1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103257479 (PLCB1)
09172 Infectious disease: viral
05163 Human cytomegalovirus infection
103257479 (PLCB1)
09174 Infectious disease: parasitic
05146 Amoebiasis
103257479 (PLCB1)
05142 Chagas disease
103257479 (PLCB1)
05143 African trypanosomiasis
103257479 (PLCB1)
09164 Neurodegenerative disease
05010 Alzheimer disease
103257479 (PLCB1)
05016 Huntington disease
103257479 (PLCB1)
05017 Spinocerebellar ataxia
103257479 (PLCB1)
05022 Pathways of neurodegeneration - multiple diseases
103257479 (PLCB1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103257479 (PLCB1)
05415 Diabetic cardiomyopathy
103257479 (PLCB1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
103257479 (PLCB1)
04934 Cushing syndrome
103257479 (PLCB1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:csyr04131]
103257479 (PLCB1)
Enzymes [BR:csyr01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
103257479 (PLCB1)
Membrane trafficking [BR:csyr04131]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
103257479 (PLCB1)
Endocytosis
Macropinocytosis
Phospholipase C
103257479 (PLCB1)
|
| SSDB |
|
| Motif |
|
| Other DBs |
|
| LinkDB |
|
| Position |
Unknown
|
| AA seq |
1114 aa
MITVVYGPDLVNISHLNLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDAFLEKAYTKLKL
QVTPEGRIPLKNIYRLFSADRKRVETALEACSLPSSRNDSIPQEDFTPDVYRVFLNNLCP
RPEIDNIFSEFGAKSKPYLTVDQMMDFINLKQRDPRLNEILYPPLKQEQVQVLIEKYEPN
SSLAKKGQISVDGFMRYLSGEENGVVSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLA
GNSSVEMYRQVLLSGCRCVELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAFK
TSPFPILLSFENHVDSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGVPLPSPMDLMYK
ILVKNKKKSHKSSEGSGKKKLSEQASNTYSDSSSVFEPSSPGAGEADTESDDDDDDDDCK
KSSMDEGTAGSEAMATEEMSNLVNYIQPVKFESFEISKKRNRSFEMSSFVETKGLEQLTK
SPVEFVEYNKMQLSRIYPKGTRVDSSNYMPQLFWNAGCQMVALNFQTMDLAMQINMGMYE
YNGKSGYRLKPEFMRRPDKHFDPFTEGIVDGIVANTLSVKIISGQFLSDKKVGTYVEVDM
FGLPVDTRRKAFKTKTSQGNAVNPVWEEEPIVFKKVVLPTLACLRIAVYEEGGKFIGHRI
LPVQAIRPGYHYICLRNERNQPLMLPAVFVYIEVKDYVPDTYADVIEALSNPIRYVNLME
QRAKQLAALTMEDEEEVKKEADPGETPSEAPSEARTTPAENGVNHTTSLAPKPPTQALHN
QPAPGSVKAPAKTEDLIQSVLTEVEAQTIEELKQQKSFVKLQKKHYKEMKDLVKRHHKKT
TDLIKEHTTKYNEIQNDYLRRRAALEKTAKKDSKKKSEPSSPDHGSSTIEQDLAALDAEM
TQKLIDLKDKQQQQLLNLRQEQYYSEKYQKREHIKLLIQKLTDVAEECQNNQLKKLKEIC
EKEKKELKKKMDKKRQEKITEAKSKDKSQMEEEKTEMIRSYIQEVVQYIKRLEEAQSKRQ
EKLLEKHKEIRQQILDEKPKLQEELEQEYQDKFKRLPLEILEFVQEAMKGKISEDSNHGS
APPSLSSDPKVNHKSPSSEELGGDIPGKEFDTPL |
| NT seq |
3345 nt +upstreamnt +downstreamnt
atgatcacagtggtgtatgggcctgaccttgtgaacatctctcatttgaaccttgtggct
ttccaagaagaagtggccaaggaatggacaaatgaggttttcagtttggcaacaaatctg
ctggcccaaaacatgtccagggacgcatttctggaaaaagcctatactaaacttaagctg
caagtcactccagaaggacgcattcctctcaaaaacatataccgcttgttttcagcagac
cggaagcgagttgaaactgctttagaggcttgtagtcttccatcttcaaggaatgattca
atacctcaagaggatttcactccagatgtgtacagagttttcctgaacaacctttgccct
cgacctgaaattgataacatcttttctgaatttggtgccaaaagcaaaccataccttacc
gttgatcagatgatggattttatcaacctgaagcagcgagatccccggctcaatgaaata
ctttacccacctttaaaacaagagcaagttcaagtattgattgagaaatatgaacccaac
agtagcctcgccaaaaaaggacagatatcagtggatggatttatgcgctatctgagtgga
gaagaaaatggagtcgtttcacctgaaaaactggatttgaatgaagacatgtctcagccc
ctttctcactatttcattaattcttcacacaacacctacctcacagctggccagctggct
ggaaactcctctgttgagatgtatcgccaagtgctcctgtctggttgtcgctgtgtggag
ctggactgctggaagggacggactgcagaagaggaacctgtcattacccatggattcacc
atgacaactgaaatatctttcaaggaagtgatagaagcgattgcagagtgtgcatttaag
acctcaccttttccaattctcctttcatttgagaaccatgtggattccccaaaacaacaa
gccaagatggctgagtactgccgactgatctttggggatgccctcctcatggagccgctg
gaaaaatacccactggaatctggagttcctcttccaagccctatggatttaatgtacaaa
attttggtgaaaaataagaagaaatcacacaagtcatccgaaggaagcggcaaaaagaag
ctctcggaacaagcctccaacacctacagcgactcttccagtgtgttcgagccctcgtcc
ccaggagctggagaagctgatacagagagtgacgatgatgacgatgatgatgactgtaaa
aaatcttcaatggacgagggaaccgctgggagtgaggccatggccacagaagagatgtct
aacttggtgaactatattcagcctgtcaagttcgagtcatttgaaatttcaaaaaaaaga
aatagaagttttgaaatgtcttcctttgtggaaaccaaaggacttgaacaacttacgaag
tctccggtggaatttgtagaatataacaaaatgcagcttagcagaatatatccaaaagga
acacgtgtggattcatccaactatatgcctcagcttttctggaatgcaggttgtcagatg
gtggcacttaatttccagacaatggacctggctatgcaaataaatatggggatgtatgaa
tacaatgggaagagtggttacagactgaagccagagttcatgaggaggcctgacaagcat
tttgatccatttactgaaggcatcgtagatgggatagtggccaacactttatctgttaag
attatttctggtcagtttctttccgataaaaaagtcgggacctacgtagaggtggatatg
tttggtttgcctgtggacacgaggaggaaggcatttaagaccaaaacatcccaaggaaat
gctgtgaatcctgtctgggaagaagaacctattgtgttcaaaaaggtggttcttcctaca
ctggcctgcttgagaatagcagtttatgaagaagggggtaaatttattggccaccggatc
ttaccagtgcaagccattcggccaggctatcactatatctgtctgaggaatgaaagaaac
cagcctctgatgctgccagctgtctttgtctacatagaagtgaaagactatgtgccagat
acatatgcagatgtgattgaagctttgtcaaacccaatccggtatgtgaatctgatggag
cagagagccaagcaactggctgctttgacaatggaagatgaggaggaagtaaagaaagag
gctgatcctggagaaacgccatcagaggctccaagtgaagcgaggacaaccccagcagaa
aatggggttaatcacactacgtccctggcacccaagccacctacccaggctctccacaat
caaccagctccaggttccgtaaaggcacctgccaaaacagaagatctcattcagagtgtc
ttaacagaagtggaggcacagaccattgaagagctaaagcaacagaaatcgttcgtgaaa
cttcaaaagaagcactacaaagaaatgaaagatcttgttaagagacaccacaagaaaacc
actgaccttatcaaagaacacactacaaaatataatgaaattcagaatgactacttgaga
aggagagcagctttggaaaagactgccaaaaaggacagtaagaaaaagtcagagcccagc
agccctgaccatggttcatcaacgattgaacaagaccttgccgccctggatgctgaaatg
acccaaaagttaatagacctgaaggacaaacaacagcaacagctgcttaatcttcggcaa
gaacagtattatagtgagaaataccagaagcgagaacatattaaactgcttattcaaaag
ttgacggatgttgctgaagagtgtcagaacaatcagttaaagaagctcaaagaaatctgt
gagaaagagaagaaggaattaaagaagaaaatggataaaaagagacaggagaagataaca
gaagctaaatccaaagacaaaagtcagatggaagaggagaagacagaaatgatccggtca
tatatccaagaggtggtacagtacattaagaggttggaagaggcgcagagtaaacggcaa
gaaaaacttttagagaaacacaaggagatacgacagcagatcctggatgaaaagcccaag
ctgcaggaggagctggagcaagaataccaagacaagttcaaaagactgccccttgagatt
ttggagttcgtgcaggaagccatgaaagggaagatcagtgaagacagcaaccatggttct
gcccctccttccctgtcctcagaccccaaagtgaatcacaagtctccctccagtgaagag
ctgggaggagacattccaggaaaagagtttgatactcctctgtaa |